MedPath

Cudetaxestat

Generic Name
Cudetaxestat
Drug Type
Small Molecule
Chemical Formula
C21H15Cl2F2N3O2S
CAS Number
1782070-21-6
Unique Ingredient Identifier
6B7TYB2MJX

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Posted: 2022/05/13
Sponsor:
Blade Therapeutics
ID:NCT05373914
Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Phase 1
Completed
Posted: 2021/06/25
Sponsor:
Blade Therapeutics
ID:NCT04939467
Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations
Phase 1
Completed
Posted: 2021/03/24
Sponsor:
Blade Therapeutics
ID:NCT04814472
Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Phase 1
Completed
Posted: 2021/03/24
Sponsor:
Blade Therapeutics
ID:NCT04814498
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects
Phase 1
Completed
Posted: 2019/10/31
Sponsor:
Blade Therapeutics
ID:NCT04146805

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy